Scientific evidence for the use of cannabidiol (CBD) and cannabigerol (CBG)

Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic

The Endocannabinoid System and its Modulation by Cannabidiol (CBD)

The reality behind cannabidiol’s medical hype

CBD and CBG can enhance the therapeutic effects of THC and reduce intoxication

CBG is superior to conventional medicines for chronic pain, anxiety, depression and insomnia

CBD and CBG combinations exhibit anti-inflammatory activity


Anxiety / Depression

Cannabidiol as an anxiolytic drug

Cannabidiol in Anxiety and Sleep: A Large Case Series

Cannabidiol as a Potential Treatment for Anxiety Disorders

Evidences for the anti-panic actions of cannabidiol

Cannabidiol induces rapid-acting antidepressant-like effects


Chronic Pain

A Balanced Approach for Cannabidiol Use in Chronic Pain

Research shows pain relieving effects of CBD

CBD and CBG oils alleviate pain and inflammation in osteoarthritis

CBG can reduce pain and inflammation in rheumatoid arthritis

Novel CBG derivatives can reduce with pain, inflammation and obesity

CBD as a treatment for peripheral neuropathy

CBG can help with chemotherapy-induced peripheral neuropathy



Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

CBD & CBG have a cytotoxic effect in glioblastoma

CBG is a potential therapeutic agent in a novel combined therapy for glioblastoma


Other medical uses

CBD treatment for psychosis to be tested in major international study

Cannabidiol as an antipsychotic drug

CBD protects nerve cells in the brain

CBD seems to be a promising treatment for autism spectrum disorder

Researchers uncover hidden antibiotic potential of cannabis

CBG can help with glaucoma

CBG is a potential therapy for high blood pressure

CBG may help with bladder dysfunction

Understanding Kratom use: A guide for healthcare providers



Highest European Court confirms that cannabidiol is not a narcotic drug and that EU Member States may not prohibit its marketing

Advocate General of the CJEU considers French ban on hemp-derived cannabidiol (CBD) contrary to EU law

Italian trade groups cheer court ruling that hemp is not a narcotic

France lifts ban on flowers as framework for CBD advances